The Uromigos

401 Episoder

1. Episode 264: Prostatectomy vs RT vs surveillance- the PROTECT trial

   Publisert: 27.9.2023
2. Episode 263: Toni Choueiri and papillary renal cancer

   Publisert: 20.9.2023
3. Episode 262: Paper of the month abiraterone +/- cabazitaxel in CRPC.

   Publisert: 12.9.2023
4. Episode 261: part 2 ctDNA in bladder cancer

   Publisert: 4.9.2023
5. Episode 260: Celeste Simon: how to make a career in translation science work.

   Publisert: 30.8.2023
6. Episode 259: Cystectomy for bladder cancer

   Publisert: 24.8.2023
7. Episode 258: Curative radiotherapy for bladder cancer: Golden Ticket Winner #1

   Publisert: 15.8.2023
8. Episode 257: Chana Weinstock from the FDA

   Publisert: 7.8.2023
9. Episode 256: ctDNA in urothelial studies.

   Publisert: 27.7.2023
10. Episode 255: How to get an academic paper accepted

    Publisert: 26.7.2023
11. Episode 254: New RCC studies at KCRS 2023 with Laurence Albiges

    Publisert: 17.7.2023
12. Episode 253: Patients' perspectives on adjuvant and 1st line RCC

    Publisert: 13.7.2023
13. Episode 252: Talazoparib and its FDA approval in CRPC

    Publisert: 4.7.2023
14. Episode 251: Final part of VEGF/TKI vs IPI/NIVO discussion

    Publisert: 26.6.2023
15. Episode 250: Bob Motzer discusses IPI/Nivo vs VEGF/PD1

    Publisert: 18.6.2023
16. Episode 249: ASCO 2023 emergency podcast IPI/NIVO vs VEGF/PD1 in kidney cancer

    Publisert: 18.6.2023
17. Episode 248: ASCO23 GU highlights

    Publisert: 14.6.2023
18. Episode 246: ASCO 2023: EV pembro and erdafitinib +/- cetrelimab in 1st line UC

    Publisert: 5.6.2023
19. Episode 245: ASCO 2023 - CONTACT-03 cabozantinib +/- atezolizumab in renal cancer

    Publisert: 5.6.2023
20. Episode 244: ASCO 2023 PEACE-1 in CRPC

    Publisert: 5.6.2023